Centre for Probe Development and Commercialization

We assist scientists and industry develop new molecular imaging probes to diagnose and treat patients and support drug discovery.

Developing and commercializing molecular imaging probes is the focus of Canada's new Centre for Probe Development and Commercialization (CPDC). The CPDC has the capability to produce agents to support drug discovery and develop novel agents to foster early detection of disease.

Image courtesy of Ron Scheffler.


Call for Proposals

Our first annual Call for Proposals gives eligible researchers an opportunity to apply for access to the Centre’s probe development and commercialization services.

Find out more >>